The Diagnostic Question Bayer Isn’t Asking
Why DSO might be the right destination reached by the wrong path BOTTOM LINE Bayer’s Dynamic Shared Ownership isn’t wrong. The diagnostic sequence is. Harvard Business School is already writing the case study. The question they’re examining: “Could fewer bosses truly drive innovation, or was this an unsustainable gamble?” CIRCA-CLEAR suggests a different question: Is … Read more